BIOVAXYS

biovaxys-logo

BioVaxys Technology Corp. is a British Columbia-registered, early stage biotechnology company that is developing viral and oncology vaccine platforms, as well as immuno-diagnostics. The Company is advancing a SARS-CoV-2 vaccine based on its haptenized viral protein technology, and is planning a clinical trial of its haptenized autologous cell vaccine used in combination with anti-PD1 and anti-PDL-1 checkpoint inhibitors that will initially be developed for ovarian cancer. Also in development is... a diagnostic for evaluating the presence or absence of a T cell immune response to SARS-CoV-2, the virus that causes COVID-19. BioVaxys has two issued US patents and two patent applications related to its cancer vaccine, and pending patent applications for its SARS-CoV-2 (Covid-19) vaccine and diagnostic technologies.

#SimilarOrganizations #People #Event #Website #More

BIOVAXYS

Social Links:

Industry:
Biopharma Biotechnology

Founded:
2018-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.biovaxys.com

Total Employee:
1+

Status:
Active

Contact:
610 977 2440

Total Funding:
4.94 M USD


Similar Organizations

alx-oncology-logo

ALX Oncology

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

Current Employees Featured

kenneth-kovan_image

Kenneth Kovan
Kenneth Kovan Founder, President & Chief Operating Officer @ BioVaxys
Founder, President & Chief Operating Officer

david-berd_image

David Berd
David Berd Founder & Chief Medical Officer @ BioVaxys
Founder & Chief Medical Officer

james-passin_image

James Passin
James Passin Founder, Chief Executive Officer & Director @ BioVaxys
Founder, Chief Executive Officer & Director

lachlan-mcleod_image

Lachlan McLeod
Lachlan McLeod Chief Financial Officer @ BioVaxys
Chief Financial Officer

Founder


david-berd_image

David Berd

james-passin_image

James Passin

kenneth-kovan_image

Kenneth Kovan

Stock Details


Company's stock symbol is CNSX:BIOV

Key Employee Changes

Date New article
2022-09-08 BioVaxys Announces New Chief Financial Officer

Official Site Inspections

http://www.biovaxys.com

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 99.83.190.102
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "BioVaxys" on Search Engine